Published in Onco Targets Ther on April 27, 2016
Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats. Int J Nanomedicine (2016) 0.75
Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen. Oncotarget (2017) 0.75
CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat Med (2013) 5.04
Minocycline-induced pigmentation. Incidence, prevention and management. Drug Saf (1998) 3.19
Ly6c+ "inflammatory monocytes" are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis. J Exp Med (2008) 3.08
Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Nat Cell Biol (2015) 2.79
Possible involvement of the M2 anti-inflammatory macrophage phenotype in growth of human gliomas. J Pathol (2008) 2.79
Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol (2010) 2.71
The brain tumor microenvironment. Glia (2011) 2.13
Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet (1988) 2.09
Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin Cancer Res (2013) 1.86
Minocycline and neurodegenerative diseases. Behav Brain Res (2008) 1.82
Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA (2005) 1.80
Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. Neuro Oncol (2009) 1.80
Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol (2005) 1.76
Recommendations for zoledronic acid treatment of patients with bone metastases. Oncologist (2005) 1.76
Preferential migration of regulatory T cells mediated by glioma-secreted chemokines can be blocked with chemotherapy. Cancer Immunol Immunother (2007) 1.70
Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Mol Med (2012) 1.64
A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. J Clin Psychiatry (2009) 1.64
Minocycline: far beyond an antibiotic. Br J Pharmacol (2013) 1.59
Tumour macrophages as potential targets of bisphosphonates. J Transl Med (2011) 1.53
Microglia during development and aging. Pharmacol Ther (2013) 1.30
Monocyte chemoattractant protein-1 expression and macrophage infiltration in gliomas. Acta Neuropathol (1997) 1.26
Human astrocytomas and glioblastomas express monocyte chemoattractant protein-1 (MCP-1) in vivo and in vitro. Int J Cancer (1994) 1.25
Minocycline for short-term neuroprotection. Pharmacotherapy (2006) 1.23
Minocycline-induced autoimmune syndromes: an overview. Semin Arthritis Rheum (1999) 1.23
Neutrophil degranulation and immunosuppression in patients with GBM: restoration of cellular immune function by targeting arginase I. Clin Cancer Res (2011) 1.22
Polymorphism in the microglial cell-mobilizing CX3CR1 gene is associated with survival in patients with glioblastoma. J Clin Oncol (2008) 1.21
Increase in tumor-associated macrophages after antiangiogenic therapy is associated with poor survival among patients with recurrent glioblastoma. Neuro Oncol (2013) 1.16
GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α. Cancer Res (2013) 1.16
Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol (1999) 1.16
Microglia and macrophages in malignant gliomas: recent discoveries and implications for promising therapies. Clin Dev Immunol (2013) 1.16
Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia (2010) 1.13
Glioma-associated microglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1. PLoS One (2015) 1.11
Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response. J Pathol (2013) 1.10
The Repurposing Drugs in Oncology (ReDO) Project. Ecancermedicalscience (2014) 1.08
Minocycline prevents retinal inflammation and vascular permeability following ischemia-reperfusion injury. J Neuroinflammation (2013) 1.08
Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers. Clin Cancer Res (2013) 1.07
Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8. Am J Physiol Heart Circ Physiol (2004) 1.06
Toll-like receptor 2 mediates microglia/brain macrophage MT1-MMP expression and glioma expansion. Neuro Oncol (2013) 1.05
Glioblastoma stem cells (GSCs) epigenetic plasticity and interconversion between differentiated non-GSCs and GSCs. Genes Dis (2015) 1.05
Minocycline reduces glioma expansion and invasion by attenuating microglial MT1-MMP expression. Brain Behav Immun (2011) 1.03
Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma. Life Sci (2011) 1.01
Zoledronic acid inhibits macrophage/microglia-assisted breast cancer cell invasion. Oncotarget (2013) 1.01
Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue. Liver Int (2009) 1.00
Angiotensin AT1 receptor antagonists exert anti-inflammatory effects in spontaneously hypertensive rats. Br J Pharmacol (2007) 1.00
Quantitative study of monocyte chemoattractant protein-1 (MCP-1) in cerebrospinal fluid and cyst fluid from patients with malignant glioma. J Natl Cancer Inst (1993) 1.00
Cytokines secreted by macrophages isolated from tumor microenvironment of inflammatory breast cancer patients possess chemotactic properties. Int J Biochem Cell Biol (2013) 0.99
Adjuvant zoledronic acid therapy for patients with early stage breast cancer: an updated systematic review and meta-analysis. J Hematol Oncol (2013) 0.98
Neutrophil infiltration into human gliomas. Acta Neuropathol (1999) 0.98
Elastase expression by infiltrating neutrophils in gliomas. Neurol Res (2000) 0.97
Minocycline inhibits the growth of glioma by inducing autophagy. Autophagy (2011) 0.97
CNS macrophages and peripheral myeloid cells in brain tumours. Acta Neuropathol (2014) 0.97
Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline. Int J Cancer (2014) 0.96
Reciprocal interactions between endothelial cells and macrophages in angiogenic vascular niches. Exp Cell Res (2013) 0.96
Zoledronic acid: a review of its use in patients with advanced cancer. Drugs (2004) 0.96
Osteopontin is up-regulated and associated with neutrophil and macrophage infiltration in glioblastoma. Immunology (2010) 0.95
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone. Neuro Oncol (2015) 0.95
Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance. Mol Ther (2014) 0.94
Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-γ activation in human monocytes. J Hypertens (2012) 0.94
Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice. PLoS One (2014) 0.94
Minocycline differentially modulates viral infection and persistence in an experimental model of Japanese encephalitis. J Neuroimmune Pharmacol (2010) 0.93
Neutrophils promote the malignant glioma phenotype through S100A4. Clin Cancer Res (2013) 0.93
Telmisartan exerts antiatherosclerotic effects by activating peroxisome proliferator-activated receptor-γ in macrophages. Arterioscler Thromb Vasc Biol (2011) 0.93
Cytokine patterns in brain tumour progression. Mediators Inflamm (2013) 0.92
Glioblastoma-derived extracellular vesicles modify the phenotype of monocytic cells. Int J Cancer (2015) 0.91
Zoledronic acid: a new parenteral bisphosphonate. Clin Ther (2003) 0.91
Doxycycline inhibits polarization of macrophages to the proangiogenic M2-type and subsequent neovascularization. J Biol Chem (2014) 0.91
Minocycline supplementation for treatment of negative symptoms in early-phase schizophrenia: a double blind, randomized, controlled trial. Schizophr Res (2014) 0.90
Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis. Oncotarget (2015) 0.89
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget (2014) 0.89
Influence of HFE variants and cellular iron on monocyte chemoattractant protein-1. J Neuroinflammation (2009) 0.89
Minocycline in acne vulgaris: benefits and risks. Am J Clin Dermatol (2010) 0.89
Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas. Cytokine (2011) 0.89
Bisphosphonates inhibit osteosarcoma-mediated osteolysis via attenuation of tumor expression of MCP-1 and RANKL. J Bone Miner Res (2014) 0.89
Increasing glioma-associated monocytes leads to increased intratumoral and systemic myeloid-derived suppressor cells in a murine model. Neuro Oncol (2014) 0.88
CC chemokine receptor-2A is frequently overexpressed in glioblastoma. J Neurooncol (2007) 0.88
Minocycline and autoimmunity. Curr Opin Pediatr (1999) 0.87
Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma. J Neurooncol (2003) 0.87
Minocycline modulates cytokine and chemokine production in lipopolysaccharide-stimulated THP-1 monocytic cells by inhibiting IκB kinase α/β phosphorylation. Transl Res (2012) 0.87
Activation of intrinsic immune responses and microglial phagocytosis in an ex vivo spinal cord slice culture model of West Nile virus infection. J Virol (2014) 0.86
The role of minocycline in the treatment of intracranial 9L glioma. J Neurosurg (1995) 0.86
GM-CSF production by glioblastoma cells has a functional role in eosinophil survival, activation, and growth factor production for enhanced tumor cell proliferation. J Immunol (2011) 0.86
A panel of four cytokines predicts the prognosis of patients with malignant gliomas. J Neurooncol (2013) 0.85
Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis. Atherosclerosis (2014) 0.85
Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neurooncol (2013) 0.85
Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study. Acta Neuropathol (2001) 0.85
Bisphosphonates modulate vital functions of human osteoblasts and affect their interactions with breast cancer cells. Breast Cancer Res Treat (2013) 0.84
Effect of telmisartan on the expression of adiponectin receptors and nicotinamide adenine dinucleotide phosphate oxidase in the heart and aorta in type 2 diabetic rats. Cardiovasc Diabetol (2012) 0.84
Differential effect of telmisartan and amlodipine on monocyte chemoattractant protein-1 and peroxisome proliferator-activated receptor-gamma gene expression in peripheral monocytes in patients with essential hypertension. Am J Cardiol (2011) 0.84
Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue. J Neuropathol Exp Neurol (2015) 0.83
Origin of microglia: current concepts and past controversies. Cold Spring Harb Perspect Biol (2015) 0.83
Chemokine expression profile of freshly isolated human glioblastoma-associated macrophages/microglia. Oncol Rep (2014) 0.83
Beyond the facts in schizophrenia: closing the gaps in diagnosis, pathophysiology, and treatment. Epidemiol Psychiatr Sci (2011) 0.83
Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice. Int J Exp Pathol (2013) 0.83
Reciprocal Supportive Interplay between Glioblastoma and Tumor-Associated Macrophages. Cancers (Basel) (2014) 0.82
Liquid biopsies in patients with diffuse glioma. Acta Neuropathol (2015) 0.82
CD47 activation-induced UHRF1 over-expression is associated with silencing of tumor suppressor gene p16INK4A in glioblastoma cells. Anticancer Res (2015) 0.82
Telmisartan. Profiles Drug Subst Excip Relat Methodol (2015) 0.82
Smac Mimetic-Induced Upregulation of CCL2/MCP-1 Triggers Migration and Invasion of Glioblastoma Cells and Influences the Tumor Microenvironment in a Paracrine Manner. Neoplasia (2015) 0.82
Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy. Int J Clin Exp Pathol (2015) 0.82
Impact of renin-angiotensin system blockade on clinical outcome in glioblastoma. Eur J Neurol (2015) 0.82
Real-time ultrasound monitoring during intracranial needle biopsies: operative results and detection of complications in 100 cases. World Neurosurg (2013) 1.47
Disulfiram/copper causes redox-related proteotoxicity and concomitant heat shock response in ovarian cancer cells that is augmented by auranofin-mediated thioredoxin inhibition. Oncoscience (2013) 0.94
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide. Oncotarget (2014) 0.89
Molecular Aspects of Bone Resorption in β-Thalassemia Major. Cell J (2015) 0.85
Erlotinib in glioblastoma: lost in translation? Anticancer Agents Med Chem (2011) 0.80
Treatment of Primary Central Nervous System Lymphoma with High-dose Methotrexate and Radiotherapy in HIV-negative Patients. Arch Iran Med (2015) 0.76
Thalidomide is more efficient than sodium butyrate in enhancing GATA-1 and EKLF gene expression in erythroid progenitors derived from HSCs with β-globin gene mutation. Int J Hematol Oncol Stem Cell Res (2016) 0.75
MicroRNA Expression in β-Thalassemia and Sickle Cell Disease: A Role in The Induction of Fetal Hemoglobin. Cell J (2016) 0.75
PCR Analysis of IgH and TCR-γ Gene Rearrangements as a Confirmatory Diagnostic Tool for Lymphoproliferative Disorders. Indian J Hematol Blood Transfus (2014) 0.75
Coexistence of p190 BCR/ABL Transcript and CALR 52-bp Deletion in Chronic Myeloid Leukemia Blast Crisis: A Case Report. Mediterr J Hematol Infect Dis (2016) 0.75
First Report of Recurrent Intramuscular Lipoma after Decompression Surgery of the Lumbar Spine. J Neurol Surg A Cent Eur Neurosurg (2015) 0.75
Anti-glioma Activity of Dapsone and Its Enhancement by Synthetic Chemical Modification. Neurochem Res (2017) 0.75
Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen. Oncotarget (2017) 0.75
The ABC7 regimen: a new approach to metastatic breast cancer using seven common drugs to inhibit epithelial-to-mesenchymal transition and augment capecitabine efficacy. Breast Cancer (Dove Med Press) (2017) 0.75
Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen. Oncotarget (2017) 0.75